Journal Article10.1016/S0022-5347(01)61700-2
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
Anthony V. D'Amico,R. Whittington,S.B. Malkowicz,Daniel Schultz,Kenneth R. Blank,Gregory A. Broderick,John E. Tomaszewski,Andrew A. Renshaw,Irving D. Kaplan,Clair J. Beard,Alan J. Wein +10 more
TL;DR: Low-risk patients had estimates of 5-year PSA outcome after treatment with RP, RT, or implant with or without neoadjuvant androgen deprivation that were not statistically different, whereas intermediate- and high- risk patients treated with RP or RT did better then those treated by implant.
read more
About: This article is published in The Journal of Urology. The article was published on 01 Apr 1999. The article focuses on the topics: PSA Failure & Prostate cancer.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Use of Advanced Treatment Technologies Among Men at Low Risk of Dying From Prostate Cancer
Bruce L. Jacobs,Yun Zhang,Florian R. Schroeck,Ted A. Skolarus,John T. Wei,James E. Montie,Scott M. Gilbert,Seth A. Strope,Rodney L. Dunn,David C. Miller,Brent K. Hollenbeck +10 more
TL;DR: The use of advanced treatment technologies among men diagnosed with prostate cancer between 2004 and 2009 who had low-risk disease, high risk of noncancer mortality, or both, the use ofAdvanced treatment technologies has increased.
135
11 C-acetate PET in the early evaluation of prostate cancer recurrence
Susanne Albrecht,Franz Buchegger,Dmitri Soloviev,Habib Zaidi,Hansjoerg Vees,Haleem G. Khan,Alain Keller,Angelika Bischof Delaloye,Osman Ratib,Raymond Miralbell +9 more
TL;DR: 11C-acetate PET was found to be valuable in the early evaluation of prostate cancer relapse, providing strong evidence for local recurrence and optimising scanning time and use of modern PET-CT equipment might allow further improvement.
Health related quality of life for men treated for localized prostate cancer with long-term followup.
TL;DR: Age at diagnosis, time from treatment and primary treatment were significant predictors of health related quality of life in all domains and men who underwent radical prostatectomy experienced the most pronounced worsening urinary function but also had the greatest recovery.
134
Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications
TL;DR: The ensemble of these molecular studies has led to suggest the existence of two main molecular groups of prostate cancers: one characterized by the presence of ERG rearrangements and by the frequent mutations in the E3 ubiquitin ligase adapter SPOP and/or deletion of CDH1, a chromatin remodeling factor.
129
Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance
Joen Sveistrup,Per Munck af Rosenschöld,Joseph O. Deasy,Jung Hun Oh,Tobias Pommer,Peter Meidahl Petersen,Svend Aage Engelholm +6 more
TL;DR: A difference in toxicity can be attributed to the combination of the IMRT technique with reduced dose to organs-at-risk, daily image guidance and margin reduction and there was no difference in biochemical progression-free survival between 3DCRT and IG-IMRT.
References
Nonparametric Estimation from Incomplete Observations
Edward L. Kaplan,Paul Meier +1 more
TL;DR: In this article, the product-limit (PL) estimator was proposed to estimate the proportion of items in the population whose lifetimes would exceed t (in the absence of such losses), without making any assumption about the form of the function P(t).
Regression Models and Life-Tables
TL;DR: The analysis of censored failure times is considered in this paper, where the hazard function is taken to be a function of the explanatory variables and unknown regression coefficients multiplied by an arbitrary and unknown function of time.
28.6K
Results of Conservative Management of Clinically Localized Prostate Cancer
Gerald W. Chodak,Ronald A. Thisted,Glenn S. Gerber,Jan-Erik Johansson,Jan Adolfsson,George W. Jones,Geoff D. Chisholm,Boaz Moskovitz,Pinhas M. Livne,John J. Warner +9 more
TL;DR: The strategy of initial conservative management and delayed hormone therapy is a reasonable choice for some men with grade 1 or 2 clinically localized prostate cancer, particularly for those who have an average life expectancy of 10 years or less.
913
Prostate Specific Antigen Based Disease Control Following Ultrasound Guided sup 125 Iodine Implantation for Stage T1/T2 Prostatic Carcinoma
TL;DR: There is a high rate of clinical and chemical freedom from progression following 125I implantation for select patients with early stage prostatic carcinoma.
274
Related Papers (5)
Nicolas Mottet,Joaquim Bellmunt,Michel Bolla,Erik Briers,Marcus G. Cumberbatch,Maria De Santis,Nicola Fossati,Tobias Gross,Ann Henry,Steven Joniau,Thomas B. Lam,Thomas B. Lam,Malcolm David Mason,Vsevolod Matveev,Paul C. Moldovan,Roderick C.N. van den Bergh,Thomas Van den Broeck,Henk G. van der Poel,Theo H. van der Kwast,Olivier Rouvière,Ivo G. Schoots,Thomas Wiegel,Philip Cornford +22 more
Geert J.L.H. van Leenders,Theodorus van der Kwast,David J. Grignon,Andrew Evans,Glen Kristiansen,Charlotte F. Kweldam,Geert Litjens,Jesse K. McKenney,Jonathan Melamed,N. Mottet,Gladell P. Paner,Hemamali Samaratunga,Ivo G. Schoots,Jeffry P. Simko,Toyonori Tsuzuki,Murali Varma,Anne Y. Warren,Thomas M. Wheeler,Sean R. Williamson,Kenneth A. Iczkowski +19 more